PSA test cuts deaths from prostate cancer, study finds

06/30/2010 | Bloomberg

A 14-year Swedish study showed that a prostate-specific antigen blood test reduced mortality from prostate cancer by nearly 50%. Researchers found that 44 of 10,000 men who were screened for prostate cancer every two years died of the disease compared with 78 of 10,000 who hadn't undergone screening.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT